Literature DB >> 3490474

Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.

O F Wagner, M Vetterlein, B R Binder.   

Abstract

24 established melanoma cell cultures were screened for their secretion of plasminogen activators and plasminogen activator inhibitors into the culture medium by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by conventional and reverse fibrin autography. Among the cell lines investigated, 22 cell lines predominantly secreting tissue type plasminogen activator (t-PA) and four cell lines additionally secreting urokinase were found. The conditioned media of two cell lines (KRFM and MJZJ) were found to contain plasminogen activator inhibitor (PAI) activity at a Mr position of approximately 50,000. The PAI of one of the two melanoma cell (MJZJ)-conditioned media found to contain PAI activity was purified to apparent homogeneity employing concanavalin A-Sepharose chromatography, gel filtration on Sephadex G-150, chromatography on Affi-Gel blue, and affinity chromatography on a Sepharose 4B immobilized monoclonal anti-t-PA IgG column. The purified melanoma PAI was found to be a single chain protein, acid stable, immunologically related to the endothelial derived PAI. In contrast to endothelial PAI, melanoma PAI presented itself in the conditioned media of the melanoma cells and in the purified preparation to an appreciable extent in its active form.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490474

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator.

Authors:  T L Lindahl; P I Ohlsson; B Wiman
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

2.  Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line.

Authors:  J C Kirchheimer; J Wojta; G Christ; B R Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

3.  Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion.

Authors:  J Bizik; A Lizonová; R W Stephens; M Grófová; A Vaheri
Journal:  Cell Regul       Date:  1990-11

4.  Hyperthermia stimulates plasminogen activator inhibitor type 1 expression in human umbilical vein endothelial cells in vitro.

Authors:  J Wojta; M Holzer; P Hufnagl; G Christ; R L Hoover; B R Binder
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

5.  Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.

Authors:  P G Tipping; P Davenport; M Gallicchio; E L Filonzi; J Apostolopoulos; J Wojta
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

6.  Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions.

Authors:  J Chmielewska; M Rånby; B Wiman
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

7.  The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical study.

Authors:  C Häckel; K Radig; I Röse; A Roessner
Journal:  Anat Embryol (Berl)       Date:  1995-10

8.  Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.

Authors:  E G Levin; L Santell
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.